Product Information
HALOPERIDOL 20 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.3711 per EA under NDC 00832156011. Its NADAC has been published 343 times since Mar 11, 2020.
FDA first approved this application on Jan 8, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832156011
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOLApproval Type
Generic (ANDA)
FDA Application
ANDA211061FDA Approved
1/8/2020
TE Code
AB
On Market Since
1/9/2020
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL 20 MG TABLET has been published 343 times since Mar 11, 2020, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3711 per EA |
|---|---|
| All-time high | $1.5897 (Jun 10, 2020) |
| All-time low | $0.2669 (Mar 18, 2026) |
| 52-week high | $0.3749 |
| 52-week low | $0.2669 |
| Median price | $0.7471 |
| Average price | $0.7538 |
| Largest weekly change | +43.8% (Dec 20, 2023) |
| Weeks tracked | 343 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL 20 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.3711 per EA (NDC 00832156011), effective Sep 30, 2026.
How has the price of HALOPERIDOL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL 20 MG TABLET has declined 76.7%. It has been tracked across 343 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL 20 MG TABLET?
Since Mar 11, 2020, the NADAC for HALOPERIDOL 20 MG TABLET has ranged from a low of $0.2669 (Mar 18, 2026) to a high of $1.5897 (Jun 10, 2020), with a median of $0.7471 per EA.
Are there cheaper alternatives to HALOPERIDOL 20 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL 20 MG TABLET, is $0.2769 per EA — about 25% below HALOPERIDOL 20 MG TABLET.
Who manufactures HALOPERIDOL 20 MG TABLET?
HALOPERIDOL 20 MG TABLET (NDC 00832156011) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.